ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,14647
0,00%
Bitcoin
60.962,26
-0,79%
Brent Oil
82,34
-0,05%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Liminal BioSciences Inc (LMNL)

  7. Liminal BioSciences Inc (LMNL) Notícias

LMNL

Liminal BioSciences (LMNL)

Liminal BioSciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:LMNL
DataHoraFonteTítuloCódigoCompanhia
06/10/202309:30Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:LMNLLiminal BioSciences Inc
27/09/202317:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LMNLLiminal BioSciences Inc
27/09/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LMNLLiminal BioSciences Inc
26/09/202310:12Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:LMNLLiminal BioSciences Inc
26/09/202310:08Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:LMNLLiminal BioSciences Inc
26/09/202309:57Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:LMNLLiminal BioSciences Inc
26/09/202309:55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LMNLLiminal BioSciences Inc
26/09/202309:54Edgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NASDAQ:LMNLLiminal BioSciences Inc
26/09/202309:00PR Newswire (US)LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LPNASDAQ:LMNLLiminal BioSciences Inc
19/09/202317:34PR Newswire (US)LIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LPNASDAQ:LMNLLiminal BioSciences Inc
15/09/202313:03PR Newswire (US)LIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LPNASDAQ:LMNLLiminal BioSciences Inc
12/09/202309:02PR Newswire (US)LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE MANAGEMENT INFORMATION CIRCULARNASDAQ:LMNLLiminal BioSciences Inc
16/08/202318:20PR Newswire (US)LIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED ARRANGEMENT WITH STRUCTURED ALPHA LPNASDAQ:LMNLLiminal BioSciences Inc
08/08/202317:05PR Newswire (US)Liminal BioSciences Reports Second Quarter Financial Results 2023NASDAQ:LMNLLiminal BioSciences Inc
12/07/202308:30PR Newswire (US)Liminal BioSciences Announces Arrangement Agreement with Structured Alpha LPNASDAQ:LMNLLiminal BioSciences Inc
05/06/202317:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:LMNLLiminal BioSciences Inc
05/06/202317:05PR Newswire (US)Liminal BioSciences Announces Voting Results of its 2023 Annual General Meeting of ShareholdersNASDAQ:LMNLLiminal BioSciences Inc
02/06/202309:00PR Newswire (US)Liminal BioSciences Provides R&D UpdateNASDAQ:LMNLLiminal BioSciences Inc
09/05/202317:05PR Newswire (Canada)Liminal BioSciences Reports First Quarter Financial Results 2023NASDAQ:LMNLLiminal BioSciences Inc
08/05/202309:00PR Newswire (US)The Special Committee of the Board of Directors of Liminal Biosciences Retains an Independent Financial Advisor in Response to Unsolicited Non-Binding Transaction ProposalNASDAQ:LMNLLiminal BioSciences Inc
05/04/202309:00PR Newswire (US)Liminal Biosciences Confirms Receipt of Unsolicited Non-Binding Transaction ProposalNASDAQ:LMNLLiminal BioSciences Inc
05/04/202308:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LMNLLiminal BioSciences Inc
05/04/202308:30PR Newswire (Canada)THOMVEST SUBMITS PROPOSAL TO ACQUIRE LIMINAL BIOSCIENCES ON AN ALL CASH BASISNASDAQ:LMNLLiminal BioSciences Inc
15/03/202317:05PR Newswire (US)Liminal BioSciences Reports Fourth Quarter and Year Ended 2022 Financial ResultsNASDAQ:LMNLLiminal BioSciences Inc
13/03/202317:05PR Newswire (US)Liminal BioSciences to Report Fourth Quarter and Year Ended 2022 Financial Results on March 15, 2023NASDAQ:LMNLLiminal BioSciences Inc
15/02/202318:05PR Newswire (US)Liminal BioSciences Regains Compliance with NASDAQ Minimum Bid Price RequirementNASDAQ:LMNLLiminal BioSciences Inc
26/01/202318:05PR Newswire (US)Liminal BioSciences Announces Reverse Stock SplitNASDAQ:LMNLLiminal BioSciences Inc
19/01/202319:05PR Newswire (US)Liminal BioSciences to Present at BIO CEO & Investor ConferenceNASDAQ:LMNLLiminal BioSciences Inc
06/01/202318:05PR Newswire (US)Liminal BioSciences Announces Priorities For 2023NASDAQ:LMNLLiminal BioSciences Inc
25/11/202210:00PR Newswire (Canada)Liminal BioSciences Announces Holding of Special Meeting of ShareholdersNASDAQ:LMNLLiminal BioSciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:LMNL

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados